Stock Quote Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iterum Therapeutics Plc (NQ: ITRM ) 1.450 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Feb 2, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.450 Bid (Size) 1.190 (6) Ask (Size) 1.550 (1) Prev. Close 1.450 Today's Range 1.450 - 1.450 52wk Range 0.6011 - 7.050 Shares Outstanding 12,233,374 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year Top News More News 12 Health Care Stocks Moving In Friday's After-Market Session January 20, 2023 Via Benzinga Iterum Therapeutics Reports Employment Inducement Grant January 11, 2023 From Iterum Therapeutics plc Via Globe NewsWire Performance YTD +57.57% +57.57% 1 Month +57.57% +57.57% 3 Month -10.49% -10.49% 6 Month -62.65% -62.65% 1 Year -75.83% -75.83% More News Read More 12 Health Care Stocks Moving In Monday's After-Market Session January 09, 2023 Via Benzinga Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session December 15, 2022 Via Benzinga Iterum Therapeutics Shares Are Surging - Read Why July 11, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 15, 2022 Via Benzinga Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem December 15, 2022 From Iterum Therapeutics plc Via Globe NewsWire 12 Health Care Stocks Moving In Thursday's After-Market Session November 24, 2022 Via Benzinga Iterum Therapeutics Reports Third Quarter 2022 Financial Results November 10, 2022 From Iterum Therapeutics plc Via Globe NewsWire Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022 November 03, 2022 From Iterum Therapeutics plc Via Globe NewsWire Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections October 20, 2022 From Iterum Therapeutics plc Via Globe NewsWire Iterum Therapeutics to Present Data at IDWeek 2022 October 17, 2022 From Iterum Therapeutics plc Via Globe NewsWire This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday August 18, 2022 Via Benzinga Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session August 17, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday August 17, 2022 Via InvestorPlace 5 Value Stocks To Watch In The Healthcare Sector August 08, 2022 Via Benzinga Boeing, PriceSmart And 80 Biggest Movers From Yesterday July 13, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session July 12, 2022 Via Benzinga Why Is Canoo Surging By 80%? 52 Stocks Moving In Tuesday's Mid-Day Session July 12, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 12, 2022 Via InvestorPlace This Healthcare Stock is Surging By Over 21%: Here's 24 Biggest Movers In Tuesday's Pre-Market July 12, 2022 Via Benzinga Alibaba, Zoom Video And 76 Biggest Movers From Yesterday July 12, 2022 Via Benzinga Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge July 11, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session July 11, 2022 Via Benzinga Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher July 11, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
